Thus, on average, the levels of E-cad protein in metastatic carcinoma cell lines remained unchanged compared to primary tumor cell lines, suggesting that E-cad protein is not downregulated in commonly occurring carcinomas when primary tumors progress to metastatic tumors. This evidence concerns the gene CDH1 and metastatic carcinoma.